Research and Markets: Triple Analysis: Colorectal Cancer, Melanoma and Prostate Cancer

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/lgj7xz/triple_analysis) has announced the addition of the "Triple Analysis: Colorectal Cancer, Melanoma and Prostate Cancer" report to their offering.

The report focuses on cancer drug development strategies in Colorectal Cancer, Melanoma and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different areas.

Synopsis

Part I: Colorectal Cancer

based on the publication: 'A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market'

The colorectal cancer report part comprises defined and up to date development strategies for 347 colorectal cancer drugs within the portfolio of 182 investigators, from Ceased to Marketed. This part extensively analyses their 210 identified drug targets, organized into 205 drug target strategies, and assesses them in eight different compound strategies in colorectal cancer.

Part II: Melanoma

based on the publication: 'Melanoma Drug Development Analysis: From First-in-Class to Best-in-Class?'

The melanoma drug report part comprises defined and up to date development strategies for 282 drugs within the portfolio of 164 companies world-wide, from Ceased to Marketed. The report extensively analyses their 226 identified drug targets, organized into 187 drug target strategies, and assesses them in melanoma.

Part III: Prostate Cancer

based on the publication: 'Competitive Handbook towards Personalized Medicine in Prostate Cancer'

The prostate cancer drug report part comprises defined and up to date development strategies for 394 drugs within the portfolio of 222 companies world-wide, from Ceased to Marketed. The report extensively analyses their 227 identified drug targets, organized into 216 drug target strategies, and assesses them in breast cancer drug development.

For more information visit http://www.researchandmarkets.com/research/lgj7xz/triple_analysis

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology, Prostate Cancer

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology, Prostate Cancer